These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 38810399)

  • 61. Nuclear factor-κB signaling inhibitors revert multidrug-resistance in breast cancer cells.
    Abdin SM; Tolba MF; Zaher DM; Omar HA
    Chem Biol Interact; 2021 May; 340():109450. PubMed ID: 33775688
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Apoptosis and cell cycle regulatory effects of adenosine by modulation of GLI-1 and ERK1/2 pathways in CD44
    Jafari SM; Joshaghani HR; Panjehpour M; Aghaei M; Zargar Balajam N
    Cell Prolif; 2017 Aug; 50(4):. PubMed ID: 28370734
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Roles of the Bcl-2/Bax ratio, caspase-8 and 9 in resistance of breast cancer cells to paclitaxel.
    Sharifi S; Barar J; Hejazi MS; Samadi N
    Asian Pac J Cancer Prev; 2014; 15(20):8617-22. PubMed ID: 25374178
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Cancer stem cell mediated acquired chemoresistance in head and neck cancer can be abrogated by aldehyde dehydrogenase 1 A1 inhibition.
    Kulsum S; Sudheendra HV; Pandian R; Ravindra DR; Siddappa G; R N; Chevour P; Ramachandran B; Sagar M; Jayaprakash A; Mehta A; Kekatpure V; Hedne N; Kuriakose MA; Suresh A
    Mol Carcinog; 2017 Feb; 56(2):694-711. PubMed ID: 27380877
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Knockdown of miR-221 promotes the cisplatin-inducing apoptosis by targeting the BIM-Bax/Bak axis in breast cancer.
    Ye Z; Hao R; Cai Y; Wang X; Huang G
    Tumour Biol; 2016 Apr; 37(4):4509-15. PubMed ID: 26503209
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Monobenzyltin Complex C1 Induces Apoptosis in MCF-7 Breast Cancer Cells through the Intrinsic Signaling Pathway and through the Targeting of MCF-7-Derived Breast Cancer Stem Cells via the Wnt/β-Catenin Signaling Pathway.
    Fani S; Dehghan F; Karimian H; Mun Lo K; Ebrahimi Nigjeh S; Swee Keong Y; Soori R; May Chow K; Kamalidehghan B; Mohd Ali H; Mohd Hashim N
    PLoS One; 2016; 11(8):e0160836. PubMed ID: 27529753
    [TBL] [Abstract][Full Text] [Related]  

  • 67. CD10
    Ffrench B; Gasch C; Hokamp K; Spillane C; Blackshields G; Mahgoub TM; Bates M; Kehoe L; Mooney A; Doyle R; Doyle B; O'Donnell D; Gleeson N; Hennessy BT; Stordal B; O'Riain C; Lambkin H; O'Toole S; O'Leary JJ; Gallagher MF
    Cell Death Dis; 2017 Oct; 8(10):e3128. PubMed ID: 29048400
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Activated ERK Signaling Is One of the Major Hub Signals Related to the Acquisition of Radiotherapy-Resistant MDA-MB-231 Breast Cancer Cells.
    Paramanantham A; Jung EJ; Go SI; Jeong BK; Jung JM; Hong SC; Kim GS; Lee WS
    Int J Mol Sci; 2021 May; 22(9):. PubMed ID: 34066541
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Cell cycle arrest and apoptogenic properties of opium alkaloids noscapine and papaverine on breast cancer stem cells.
    Sajadian S; Vatankhah M; Majdzadeh M; Kouhsari SM; Ghahremani MH; Ostad SN
    Toxicol Mech Methods; 2015; 25(5):388-95. PubMed ID: 25980655
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Citral induced apoptosis in MDA-MB-231 spheroid cells.
    Nigjeh SE; Yeap SK; Nordin N; Kamalideghan B; Ky H; Rosli R
    BMC Complement Altern Med; 2018 Feb; 18(1):56. PubMed ID: 29433490
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Regulation mechanism of breast cancer resistance protein by toremifene to reverse BCRP-mediated multidrug resistance in breast cancer cells].
    Zhang YH; Li G; Yu J; Xu MS; Liu ZX
    Zhonghua Zhong Liu Za Zhi; 2011 Sep; 33(9):654-60. PubMed ID: 22340044
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Lidocaine sensitizes the cytotoxicity of cisplatin in breast cancer cells via up-regulation of RARβ2 and RASSF1A demethylation.
    Li K; Yang J; Han X
    Int J Mol Sci; 2014 Dec; 15(12):23519-36. PubMed ID: 25526566
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Comprehensive Analysis of the Chemical Composition and In Vitro Cytotoxic Mechanisms of Pallines Spinosa Flower and Leaf Essential Oils Against Breast Cancer Cells.
    Saleh AM; Al-Qudah MA; Nasr A; Rizvi SA; Borai A; Daghistani M
    Cell Physiol Biochem; 2017; 42(5):2043-2065. PubMed ID: 28803233
    [TBL] [Abstract][Full Text] [Related]  

  • 74. MiR-24 induces chemotherapy resistance and hypoxic advantage in breast cancer.
    Roscigno G; Puoti I; Giordano I; Donnarumma E; Russo V; Affinito A; Adamo A; Quintavalle C; Todaro M; Vivanco MD; Condorelli G
    Oncotarget; 2017 Mar; 8(12):19507-19521. PubMed ID: 28061479
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [Sensitivity to chemotherapeutic drugs of polyploid tumor cells induced by a spindle poison nocodazole].
    Hao J; Yuan BB; Xu YF; Yu J; Liu GY; Wang DH
    Zhonghua Zhong Liu Za Zhi; 2012 Jun; 34(6):419-24. PubMed ID: 22967442
    [TBL] [Abstract][Full Text] [Related]  

  • 76. MiR-148a suppressed cell invasion and migration via targeting WNT10b and modulating β-catenin signaling in cisplatin-resistant colorectal cancer cells.
    Shi L; Xi J; Xu X; Peng B; Zhang B
    Biomed Pharmacother; 2019 Jan; 109():902-909. PubMed ID: 30551544
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Stellera chamaejasme extract against multidrug resistance of breast cancer cell line MCF-7].
    Cui XH; Zeng R; Zang YL; Yang Q; Zhu XX; Wang YJ
    Zhongguo Zhong Yao Za Zhi; 2023 May; 48(9):2360-2367. PubMed ID: 37282865
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Napabucasin Attenuates Resistance of Breast Cancer Cells to Tamoxifen by Reducing Stem Cell-Like Properties.
    Liu X; Huang J; Xie Y; Zhou Y; Wang R; Lou J
    Med Sci Monit; 2019 Nov; 25():8905-8912. PubMed ID: 31760402
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Determination of the target proteins in chemotherapy resistant breast cancer stem cell-like cells by protein array.
    Kars MD; Yıldırım G
    Eur J Pharmacol; 2019 Apr; 848():23-29. PubMed ID: 30707960
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Regulation of AKT phosphorylation by GSK3β and PTEN to control chemoresistance in breast cancer.
    Gao C; Yuan X; Jiang Z; Gan D; Ding L; Sun Y; Zhou J; Xu L; Liu Y; Wang G
    Breast Cancer Res Treat; 2019 Jul; 176(2):291-301. PubMed ID: 31006103
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.